(Q79614212)
Statements
Phase I, open-label, single-center, multiple-dose, dose-escalation clinical study of SUO11248 (sunitinib) in subjects with high-risk prostate cancer who have elected to undergo radical prostatectomy (English)
Allan J Pantuck
Nazy Zomorodian
Arie S Belldegrun
1 January 2007
1 reference
1 reference
1 reference
1 reference
1 reference